Complications of Implantable Cardioverter Defibrillator and Their Potential Risk Factors in Patients with Hypertrophic Cardiomyopathy

被引:0
作者
Goudarzi, Mohammad Taghi Hedayati [1 ]
Moradi, Maryam [2 ]
Abrotan, Saeed [1 ]
Saravi, Mehrdad [2 ]
Shirafkan, Hoda [3 ]
Irilouzadian, Rana [4 ]
Omran, Hossein Salehi [1 ]
机构
[1] Babol Univ Med Sci, Rohani Hosp, Sch Med, Dept Cardiol, Babol, Iran
[2] Babol Univ Med Sci, Fac Med, Dept Cardiol, Babol, Iran
[3] Babol Univ Med Sci, Hlth Res Inst, Social Determinants Hlth Res Ctr, Babol, Iran
[4] Iran Univ Med Sci, Burn Res Ctr, Tehran, Iran
关键词
SUDDEN-DEATH; TASK-FORCE; THERAPY; POPULATION; PREVENTION; EFFICACY; OUTCOMES; SOCIETY;
D O I
10.1155/2023/4552100
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Hypertrophic cardiomyopathy (HCM) has different complications such as cardiac arrhythmia and sudden cardiac death (SCD). Insertion of an implantable cardioverter defibrillator (ICD) is recommended for HCM patients who are at high risk of SCD and malignant arrhythmias, despite having their own potential complications. Hypothesis. We aimed to investigate the prevalence of different complications of ICD insertion and the impact of the potential influential baseline characteristics in a one-year follow-up period. Methods. This was a retrospective study with a total of 71 HCM patients with ICD insertion. We evaluated the prevalence of different complications of ICD implantation and the impact of baseline characteristics on the occurrence of ICD complications using multivariate regression analysis in three 4-month periods. Results. In a one-year follow-up, 13 patients (18.3%) experienced at least one of the complications including pneumothorax, lead failure, ICD infection, inappropriate shocks, perforation, and upper limb deep vein thrombosis (DVT) with no mortality. Inappropriate shocks were reported as the most common (11.3%) complication during this period, with a gradual increase in the second (4.2%) and third (5.6%) follow-up sessions. Among all of the baseline characteristics that were investigated in this study, a positive history of hypertension was the only risk factor with significant impact on the occurrence of complications (P = 0.01). Conclusion. We demonstrated the occurrence of complications during a one-year follow-up as 18.3% in HCM patients with ICD insertion. A positive history of hypertension was the only baseline characteristic affecting the occurrence of complications, and inappropriate shocks were the most common complication.
引用
收藏
页数:7
相关论文
共 20 条
[1]   Population Burden of Sudden Death Associated With Hypertrophic Cardiomyopathy [J].
Aro, Aapo L. ;
Nair, Sandeep G. ;
Reinier, Kyndaron ;
Jayaraman, Reshmy ;
Stecker, Eric C. ;
Uy-Evanado, Audrey ;
Rusinaru, Carmen ;
Jui, Jonathan ;
Chugh, Sumeet S. .
CIRCULATION, 2017, 136 (17) :1665-+
[2]   Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy [J].
Elliott, P. M. ;
Gimeno, J. R. ;
Thaman, R. ;
Shah, J. ;
Ward, D. ;
Dickie, S. ;
Esteban, M. T. Tome ;
McKenna, W. J. .
HEART, 2006, 92 (06) :785-791
[3]   2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC) [J].
Elliott, Perry M. ;
Anastasakis, Aris ;
Borger, Michael A. ;
Borggrefe, Martin ;
Cecchi, Franco ;
Charron, Philippe ;
Hagege, Albert Alain ;
Lafont, Antoine ;
Limongelli, Giuseppe ;
Mahrholdt, Heiko ;
McKenna, William J. ;
Mogensen, Jens ;
Nihoyannopoulos, Petros ;
Nistri, Stefano ;
Pieper, Petronella G. ;
Pieske, Burkert ;
Rapezzi, Claudio ;
Rutten, Frans H. ;
Tillmanns, Christoph ;
Watkins, Hugh .
EUROPEAN HEART JOURNAL, 2014, 35 (39) :2733-+
[4]   Long-term follow-up of subcutaneous ICD systems in patients with hypertrophic cardiomyopathy: a single-center experience [J].
Frommeyer, Gerrit ;
Dechering, Dirk G. ;
Zumhagen, Sven ;
Loeher, Andreas ;
Koebe, Julia ;
Eckardt, Lars ;
Reinke, Florian .
CLINICAL RESEARCH IN CARDIOLOGY, 2016, 105 (01) :89-93
[5]  
Ghavami Ghanbarabadi V., 2013, Journal of Birjand University of Medical Sciences, V20, P94
[6]  
HARDARSON T, 1973, LANCET, V2, P1462
[7]   ECHOCARDIOGRAPHIC MEASUREMENT OF LEFT VENTRICULAR OUTFLOW GRADIENT IN IDIOPATHIC HYPERTROPHIC SUBAORTIC STENOSIS [J].
HENRY, WL ;
CLARK, CE ;
GLANCY, DL ;
EPSTEIN, SE .
NEW ENGLAND JOURNAL OF MEDICINE, 1973, 288 (19) :989-993
[8]   Evaluation of subcutaneous ICD early performance in hypertrophic cardiomyopathy from the pooled EFFORTLESS and IDE cohorts [J].
Lambiase, Pier D. ;
Gold, Michael R. ;
Hood, Margaret ;
Boersma, Lucas ;
Theuns, Dominic A. M. J. ;
Burke, Martin C. ;
Weiss, Raul ;
Russo, Andrea M. ;
Kaab, Stefan ;
Knight, Bradley P. .
HEART RHYTHM, 2016, 13 (05) :1066-1074
[9]   Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy [J].
Lin, G. ;
Nishimura, R. A. ;
Gersh, B. J. ;
Phil, D. ;
Ommen, S. R. ;
Ackerman, M. J. ;
Brady, P. A. .
HEART, 2009, 95 (09) :709-714
[10]   Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy [J].
Maron, Barry J. ;
Spirito, Paolo ;
Shen, Win-Kuang ;
Haas, Tammy S. ;
Formisano, Francesco ;
Link, Mark S. ;
Epstein, Andrew E. ;
Almquist, Adrian K. ;
Daubert, James P. ;
Lawrenz, Thorsten ;
Boriani, Giuseppe ;
Estes, N. A. Mark, III ;
Favale, Stefano ;
Piccininno, Marco ;
Winters, Stephen L. ;
Santini, Massimo ;
Betocchi, Sandro ;
Arribas, Fernando ;
Sherrid, Mark V. ;
Buja, Gianfranco ;
Semsarian, Christopher ;
Bruzzi, Paolo .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (04) :405-412